Clinical Trials Logo

Invader Fungal Infection clinical trials

View clinical trials related to Invader Fungal Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT00386802 Completed - Clinical trials for Invader Fungal Infection

Antifungal Use in Oncohematological Neutropenic Patients

Start date: August 2006
Phase: Phase 4
Study type: Interventional

Primary purpose: Frequency of use of broad-spectrum antifungals in the episode of neutropenia. Secondary purposes:To determine the safety and toxicity measure by: 1. Frequency of Invader Fungal Infection. 2. Frequency of global use of broad-spectrum antifungals as amphotericine, itraconazole, voriconazole, caspofungin, terbinafine, during the period of study. 3. Mortality 4. Development of nephrotoxicity 5. Use of galactomannan in this clinical context 6. Time of administration of empirical antifungal therapy of broad-spectrum.